BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5044515)

  • 1. Measurement of the binding of antifibrinolytic amino acids to various plasminogens.
    Brockway WJ; Castellino FJ
    Arch Biochem Biophys; 1972 Jul; 151(1):194-9. PubMed ID: 5044515
    [No Abstract]   [Full Text] [Related]  

  • 2. Rotational diffusion analysis of the conformational alterations produced in plasminogen by certain antifibrinolytic amino acids.
    Castellino FJ; Brockway WJ; Thomas JK; Liano HT; Rawitch AB
    Biochemistry; 1973 Jul; 12(15):2787-91. PubMed ID: 4737010
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor.
    Abiko Y; Iwamoto M; Tomikawa M
    Biochim Biophys Acta; 1969; 185(2):424-31. PubMed ID: 4241289
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction of streptokinase with human, cat, dog, and rabbit plasminogens. The fragmentation of streptokinase in the equimolar plasminogen-streptokinase complexes.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1974 Aug; 249(15):4760-9. PubMed ID: 4846746
    [No Abstract]   [Full Text] [Related]  

  • 6. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiplicity of rabbit plasminogen. Physical characterization.
    Sodetz JM; Brockway WJ; Castellino FJ
    Biochemistry; 1972 Nov; 11(24):4451-8. PubMed ID: 4653125
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 9. Some observations on the affinity chromatography of rabbit plasminogen.
    Hatton MW; Regoeczi E
    Biochim Biophys Acta; 1974 Jul; 359(1):55-65. PubMed ID: 4546567
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 12. Some properties of the tissue plasminogen activator from the pig heart.
    Hijikata A; Fujimoto K; Kitaguchi H; Okamoto S
    Thromb Res; 1974 Jun; 4(6):731-40. PubMed ID: 4844057
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of plasmin-free human plasminogen with N-terminal glutamic acid.
    Rickli EE; Cuendet PA
    Biochim Biophys Acta; 1971 Nov; 250(2):447-51. PubMed ID: 5143348
    [No Abstract]   [Full Text] [Related]  

  • 14. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human plasmins formed by activation with trace and large amounts of streptokinase.
    Muramatu M; Hayakumo Y; Onishi T; Sato T; Fujii S
    J Biochem; 1969 Mar; 65(3):329-42. PubMed ID: 4239752
    [No Abstract]   [Full Text] [Related]  

  • 17. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 18. NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1973 Oct; 248(20):7242-6. PubMed ID: 4270330
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and characterization of bovine plasminogen activator from a human plasminogen-streptokinase mixture.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1967 Apr; 242(7):1419-25. PubMed ID: 4960668
    [No Abstract]   [Full Text] [Related]  

  • 20. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.